We are live on ! Find out more
ALTU

Altus Pharmaceuticals
ALTU

Delisted

ALTU was delisted on the 20th of November, 2009.

Back to rankings

1 hedge funds and large institutions have $1K invested in Altus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $1K → $1K ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCP
1
Syntal Capital Partners
Texas
$1K – – –

ALTU Hedge Fund Activity: Q3 2019 in Review

1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Altus Pharmaceuticals (ALTU) for Q3 2019, worth a combined $1K — unchanged from a quarter earlier.

Fund positioning in ALTU was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Altus Pharmaceuticals (ALTU) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $1K of Altus Pharmaceuticals stock for Q3 2019, unchanged quarter-over-quarter.
  • 0 funds opened new Altus Pharmaceuticals positions in Q3 2019 and 0 closed out.

Based on aggregated 13F filings for Q3 2019.